Biorab-L 25 Tablets
Rabeprazole 20 mg (Enteric Coated) + Levosulpiride 25 mg (Sustained Release)
Dual Action Therapy for Acid Reflux, Functional Dyspepsia and Gastrointestinal Motility Disorders.
Dual Action Therapy for Superior Gastrointestinal Relief
Biorab-L 25 Tablets combine the acid-suppressing action of Rabeprazole 20 mg (Enteric Coated) with the prokinetic benefits of Levosulpiride 25 mg (Sustained Release), offering comprehensive management of Gastroesophageal Reflux Disease (GERD), Functional Dyspepsia, Acid Peptic Disorders, delayed gastric emptying, bloating and nausea.
Rabeprazole rapidly suppresses gastric acid secretion, while Levosulpiride enhances gastric emptying and improves gastrointestinal motility. Together they provide effective symptom relief and improve patient comfort.
Composition
| Ingredient | Strength |
|---|---|
| Rabeprazole Sodium (Enteric Coated) | 20 mg |
| Levosulpiride (Sustained Release) | 25 mg |
Dual Mechanism for Superior Gastrointestinal Relief
Biorab-L25 combines the proven acid-suppressing action of Rabeprazole with the prokinetic benefits of Levosulpiride, providing comprehensive management of GERD, Functional Dyspepsia and associated gastrointestinal motility disorders.
Rabeprazole 20 mg
Proton Pump Inhibitor
- Rapid Acid Suppression
- Long-lasting Acid Control
- Promotes Ulcer Healing
- Reduces Heartburn
- Controls GERD Symptoms
Dual Action
Better Relief
Levosulpiride 25 mg SR
Prokinetic Agent
- Improves Gastric Emptying
- Enhances GI Motility
- Relieves Bloating
- Controls Nausea
- Reduces Post-meal Fullness
Better Symptom Relief
Improved Patient Comfort
Trusted by Physicians
Vowcare Quality
Why Choose Biorab-L 25?
Biorab-L 25 combines effective acid suppression with improved gastrointestinal motility, providing comprehensive relief for GERD, Functional Dyspepsia and associated gastric disorders.
Dual Mechanism
Combines acid suppression with prokinetic action.
Faster Relief
Rapid improvement in reflux and dyspepsia symptoms.
Better Gastric Emptying
Supports healthy gastric motility and digestion.
Controls Acid Reflux
Effectively reduces gastric acid secretion.
Heartburn Relief
Provides long-lasting comfort from heartburn.
Functional Dyspepsia
Helps relieve upper abdominal discomfort.
Reduces Bloating
Improves digestive comfort after meals.
Controls Nausea
Improves patient comfort and wellbeing.
Better Compliance
Convenient therapy helps improve adherence.
Once Daily
Administer as prescribed by the physician.
Recommended For Clinical Use
Biorab-L 25 Tablets may be prescribed by healthcare professionals for the management of acid-related disorders associated with impaired gastrointestinal motility.
GERD
Effective relief from Gastroesophageal Reflux Disease.
Functional Dyspepsia
Controls upper abdominal discomfort and indigestion.
Acid Peptic Disorders
Long-lasting acid suppression for better symptom control.
Gastritis
Helps relieve gastric irritation and inflammation.
Post-meal Fullness
Improves gastric emptying and digestive comfort.
Bloating
Reduces abdominal bloating and gastric distension.
Nausea
Relieves nausea associated with gastric dysmotility.
Delayed Gastric Emptying
Enhances gastric motility for improved digestion.
Clinical Note: The combination of a Proton Pump Inhibitor (Rabeprazole) with Levosulpiride is commonly prescribed in patients with GERD and Functional Dyspepsia where impaired gastric motility contributes to persistent symptoms. Prescribing decisions should always be made by a qualified healthcare professional based on individual patient needs.